Heilongjiang ZBD Pharmaceutical Co. Ltd. A | Ownership
Companies that own Heilongjiang ZBD Pharmaceutical Co. Ltd. A
Guotai Junan Allianz Fund Management Co., Ltd.
1,002,768
0.37%
1,002,768
0.12%
09/30/2017
China Southern Asset Management Co., Ltd.
731,550
0.27%
-23,000
0.01%
09/30/2017
The Vanguard Group, Inc.
370,400
0.14%
0
0%
07/31/2018
GF Fund Management Co., Ltd.
104,800
0.04%
-60,000
0%
12/31/2017
CR Yuanta Fund Management Co.,Ltd
94,600
0.04%
94,600
0.1%
12/31/2017
BlackRock Asset Management North Asia Ltd.
65,200
0.02%
5,900
0%
01/31/2018
Truvalue Asset Management Co. Ltd.
45,900
0.02%
-531,745
0.01%
12/31/2017
Morgan Stanley Huaxin Fund Management Co., Ltd.
27,400
0.01%
-22,300
0.01%
12/31/2017
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
9,200
0%
-2,300
0%
12/31/2016
China Post & Capital Fund Management Co., Ltd.
5,000
0%
-1,500
0%
12/31/2017
| Address |
8 Yantai 1st Road
Harbin Heilongjiang 150060
China
|
|
Employees
|
- |
| Website |
http://www.zbdzy.com |
| Updated |
07/08/2019 |
| HeiLongJiang ZBD Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine. It also engages in the trading of drug and Chinese herbal medicine. Its business areas include Industrial and Commercial. |
